Investigating the role of small extracellular vesicles in insulin action related to obesity
Official title: Effect of Small Extracellular Vesicles From Adipose Tissue on Insulin Action
Run by Washington University School of Medicine · NCT05933707 · Data updated 2026-11-12
This study is testing how tiny particles in the blood from people with obesity might affect insulin action to see why some people stay healthy despite being overweight.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years to 55 Years |
| Sex | All |
| Enrollment | 72 (estimated) |
| Sponsor | Washington University School of Medicine Academic / other |
| Locations | 1 site (St Louis, Missouri) |
| Status | Recruiting |
| Started | June 14, 2023 |
| Main results expected | June 1, 2028 |
| Study ends | August 31, 2028 |
| Registry record updated | July 17, 2026 |
| Trial ID | NCT05933707 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with metabolically healthy obesity, metabolically unhealthy obesity, or metabolically healthy lean individuals.
✕Probably not a fit
Patients with a history of diabetes or serious liver diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research aims to understand the differences in metabolic health among individuals with obesity, focusing on those who are metabolically healthy versus those who are not. The study will isolate small extracellular vesicles (sEVs) from participants' blood and adipose tissue to assess their effects on insulin sensitivity in cultured cells and in mice. By examining the bioactive molecules carried by these vesicles, the researchers hope to uncover mechanisms that protect some individuals from obesity-related metabolic diseases. The findings could provide insights into potential therapeutic targets for improving insulin action in those with obesity.
Why it matters
Potential benefit: If successful, this study could lead to new strategies for preventing or treating insulin resistance and related metabolic diseases in obese patients.
How similar studies have gone: While the specific approach of using sEVs in this context is novel, related studies have shown promise in understanding metabolic health and insulin resistance.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Metabolically healthy lean subjects must have a BMI ≥18.5 and ≤24.9 kg/m²; Subjects with obesity must have a BMI ≥30.0 and ≤50.0 kg/m² * Metabolically healthy lean and people with metabolically healthy obesity must have intrahepatic triglyceride (IHTG) content ≤5%; fasting plasma glucose concentration \<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration \<140 mg/dl, hemoglobin A 1C (HbA1c) ≤5.6% and HOMA-IR \<2.5. * People with metabolically unhealthy obesity must have intrahepatic triglyceride (IHTG) content ≥5.6%; HOMA-IR ≥2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucose concentration ≥100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucose concentration ≥140 mg/dl. Exclusion Criteria: * History of diabetes, liver disease other than NAFLD or other serious diseases, * Consume excessive amounts of alcohol (\>21 units/week for men and \>14 units/week for women), * Take medications that could affect the study outcome measures, engage in regular exercise (\>120 min/week), * Are pregnant or lactating
Where it's running
-
Washington University School of Medicine
St Louis, Missouri, United States Recruiting
Study contacts
- Principal investigator: Dmitri Samovski, PhD — Washington University School of Medicine
- Study coordinator: Kyle Timmons
- Email: nutritionresearch@wustl.edu
- Phone: 3142731879
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lowering insulin to reduce liver fat production
This study will try a short course of diazoxide to lower insulin and see if it reduces the liver's creation of new fat in adults with obesity, insulin resistance, and MASLD.
-
Electro-acupuncture for adults with obesity and insulin resistance
This study will test whether electro-acupuncture can improve insulin resistance in adults with obesity.
-
Investigating mitochondrial dysfunction in women with PCOS and infertility
This study is trying to see if problems with energy production in cells are linked to polycystic ovary syndrome (PCOS) and infertility in women.
-
Endoscopic sleeve gastroplasty for people with obesity and MASH
This study will test whether endoscopic sleeve gastroplasty plus lifestyle changes helps adults with obesity and MASH lose weight and improve liver health compared with lifestyle changes alone.
-
Impact of weight loss on fat tissue signaling in muscles
This study is testing how losing weight affects fat tissue in muscles and whether it helps people with obesity improve their insulin sensitivity.
-
Timed-Restricted Eating for Improving Metabolic Health
This study is testing whether changing when people with obesity and insulin resistance eat can improve their metabolic health, liver fat, brain function, inflammation, and sleep quality.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.